{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:57:49Z","timestamp":1790708269528,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"DOI":"10.1007\/s00774-026-01767-3","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:01:58Z","timestamp":1790704918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative effects of roxadustat and epoetin beta on lumbar trabecular BMD in dialysis patients"],"prefix":"10.1007","author":[{"given":"Mostafa","family":"Alaskary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Sobh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ashraf","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina Abd Elnasser","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Atef","family":"Warda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael Ibrahim","family":"Mortada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Maher","family":"Elashmawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdalbary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"1767_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ki.2013.279","volume":"85","author":"F Tentori","year":"2014","unstructured":"Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM et al (2014) High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 85:166\u2013173. https:\/\/doi.org\/10.1038\/ki.2013.279","journal-title":"Kidney Int"},{"key":"1767_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1055\/s-0043-1770353","volume":"27","author":"MH Lafage-Proust","year":"2023","unstructured":"Lafage-Proust MH (2023) Bone and chronic kidney disease. Semin Musculoskelet Radiol 27:463\u2013470. https:\/\/doi.org\/10.1055\/s-0043-1770353","journal-title":"Semin Musculoskelet Radiol"},{"key":"1767_CR3","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","volume":"361","author":"MA Pfeffer","year":"2009","unstructured":"Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D et al (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361:2019\u20132032. https:\/\/doi.org\/10.1056\/NEJMoa0907845","journal-title":"N Engl J Med"},{"key":"1767_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/jpet.120.265181","volume":"374","author":"U Del Balzo","year":"2020","unstructured":"Del Balzo U, Signore PE, Walkinshaw G, Seeley TW, Brenner MC et al (2020) Nonclinical characterization of the hypoxia-inducible factor prolyl hydroxylase inhibitor Roxadustat, a novel treatment of anemia of chronic kidney disease. J Pharmacol Exp Ther 374:342\u2013353. https:\/\/doi.org\/10.1124\/jpet.120.265181","journal-title":"J Pharmacol Exp Ther"},{"key":"1767_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12020-022-03199-1","volume":"79","author":"L Li","year":"2023","unstructured":"Li L, Li A, Gan L, Zuo L (2023) Roxadustat improves renal osteodystrophy by dual regulation of bone remodeling. Endocrine 79:180\u2013189. https:\/\/doi.org\/10.1007\/s12020-022-03199-1","journal-title":"Endocrine"},{"key":"1767_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13018-022-03162-w","volume":"17","author":"L Li","year":"2022","unstructured":"Li L, Li A, Zhu L, Gan L, Zuo L (2022) Roxadustat promotes osteoblast differentiation and prevents estrogen deficiency-induced bone loss by stabilizing HIF-1\u03b1 and activating the Wnt\/\u03b2-catenin signaling pathway. J Orthop Surg Res 17:286. https:\/\/doi.org\/10.1186\/s13018-022-03162-w","journal-title":"J Orthop Surg Res"},{"key":"1767_CR7","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/sctm.20-0387","volume":"10","author":"KM Lappin","year":"2021","unstructured":"Lappin KM, Mills KI, Lappin TR (2021) Erythropoietin in bone homeostasis-implications for efficacious anemia therapy. Stem Cells Transl Med 10:836\u2013843. https:\/\/doi.org\/10.1002\/sctm.20-0387","journal-title":"Stem Cells Transl Med"},{"key":"1767_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-056390","volume":"12","author":"CY Cheng","year":"2022","unstructured":"Cheng CY, Kuo YJ (2022) Single-centre cross-sectional study on the impact of cumulative erythropoietin on bone mineral density in maintenance dialysis patients. BMJ Open 12:e056390. https:\/\/doi.org\/10.1136\/bmjopen-2021-056390","journal-title":"BMJ Open"},{"key":"1767_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11050772","author":"A Pimentel","year":"2021","unstructured":"Pimentel A, Bover J, Elder G, Cohen-Solal M, Ure\u00f1a-Torres PA (2021) The use of imaging techniques in chronic kidney disease-mineral and bone disorders (CKD-MBD)-a systematic review. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics11050772","journal-title":"Diagnostics (Basel)"},{"key":"1767_CR10","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1093\/ndt\/10.12.2253","volume":"10","author":"P Van der Niepen","year":"1995","unstructured":"Van der Niepen P, Sennesael J, Louis O, Verbeelen D (1995) Effect of treatment with 1.25 and 1.75 mmol\/l calcium dialysate on bone mineral density in haemodialysis patients. Nephrol Dial Transpl 10:2253\u20132258. https:\/\/doi.org\/10.1093\/ndt\/10.12.2253","journal-title":"Nephrol Dial Transpl"},{"key":"1767_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081123","volume":"389","author":"S Hopewell","year":"2025","unstructured":"Hopewell S, Chan AW, Collins GS, Hr\u00f3bjartsson A, Moher D et al (2025) CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ (Clinical research ed) 389:e081123. https:\/\/doi.org\/10.1136\/bmj-2024-081123","journal-title":"BMJ (Clinical research ed)"},{"key":"1767_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-025-04475-6","volume":"91","author":"J Yu","year":"2025","unstructured":"Yu J, Lei Z, Chen Y, Yao R, Qi X et al (2025) Effect of Roxadustat on bone metabolism markers in patients with renal anemia. Endocrine 91:10. https:\/\/doi.org\/10.1007\/s12020-025-04475-6","journal-title":"Endocrine"},{"key":"1767_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30331-6","volume":"13","author":"S Yoshida","year":"2023","unstructured":"Yoshida S, Saito T, Shibagaki K, Hirao K, Yuza T et al (2023) Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with roxadustat in patients on hemodialysis. Sci Rep 13:3181. https:\/\/doi.org\/10.1038\/s41598-023-30331-6","journal-title":"Sci Rep"},{"key":"1767_CR14","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/ckj\/sfad084","volume":"16","author":"Z Wang","year":"2023","unstructured":"Wang Z, Xu X, Song D, Yang B, Xu Y et al (2023) Effect of roxadustat on intact and C-terminal FGF23 levels in patients undergoing peritoneal dialysis: a post hoc analysis of a randomized trial. Clin Kidney J 16:1703\u20131705. https:\/\/doi.org\/10.1093\/ckj\/sfad084","journal-title":"Clin Kidney J"},{"key":"1767_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jbmr\/zjaf032","volume":"40","author":"YY Zhu","year":"2025","unstructured":"Zhu YY, Zhang DF, Tong XW, Zhao WM, Shi R et al (2025) Roxadustat increases markers of calcification in patients with end-stage kidney disease: prospective cohort study. J Bone Miner Res 40:492\u2013499. https:\/\/doi.org\/10.1093\/jbmr\/zjaf032","journal-title":"J Bone Miner Res"},{"key":"1767_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00198-017-4228-4","volume":"29","author":"HH Malluche","year":"2018","unstructured":"Malluche HH, Monier-Faugere MC, Blomquist G, Davenport DL (2018) Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors. Osteoporos Int 29:125\u2013134. https:\/\/doi.org\/10.1007\/s00198-017-4228-4","journal-title":"Osteoporos Int"},{"key":"1767_CR17","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/jbmr.1916","volume":"28","author":"TL Nickolas","year":"2013","unstructured":"Nickolas TL, Stein EM, Dworakowski E, Nishiyama KK, Komandah-Kosseh M et al (2013) Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res 28:1811\u20131820. https:\/\/doi.org\/10.1002\/jbmr.1916","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-026-01767-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-026-01767-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-026-01767-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:01:59Z","timestamp":1790704919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-026-01767-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":17,"alternative-id":["1767"],"URL":"https:\/\/doi.org\/10.1007\/s00774-026-01767-3","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"5 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared that no conflict of interest exists\n                      .","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}